499 related articles for article (PubMed ID: 24493493)
1. Anticoagulation and antiplatelet therapy in acute coronary syndromes.
Singh D; Gupta K; Vacek JL
Cleve Clin J Med; 2014 Feb; 81(2):103-14. PubMed ID: 24493493
[TBL] [Abstract][Full Text] [Related]
2. Antiplatelet and anticoagulation agents in acute coronary syndromes: what is the current status and what does the future hold?
Huber K; Bates ER; Valgimigli M; Wallentin L; Kristensen SD; Anderson JL; Lopez Sendon JL; Tubaro M; Granger CB; Bode C; Ohman EM; Steg PG
Am Heart J; 2014 Nov; 168(5):611-21. PubMed ID: 25440788
[TBL] [Abstract][Full Text] [Related]
3. [New antithrombotic drugs].
Mustonen P; Puurunen M
Duodecim; 2012; 128(7):707-18. PubMed ID: 22612021
[TBL] [Abstract][Full Text] [Related]
4. Anticoagulants for the treatment of acute coronary syndrome in the era of new oral agents.
Kar S; Bhatt DL
Coron Artery Dis; 2012 Sep; 23(6):380-90. PubMed ID: 22728913
[TBL] [Abstract][Full Text] [Related]
5. [Anticoagulant therapy in secondary prevention of coronary events].
Bultas J
Vnitr Lek; 2014 Dec; 60(12):1023-32. PubMed ID: 25692828
[TBL] [Abstract][Full Text] [Related]
6. Anticoagulant and antiplatelet medications encountered in emergency surgery patients: a review of reversal strategies.
Gordon JL; Fabian TC; Lee MD; Dugdale M
J Trauma Acute Care Surg; 2013 Sep; 75(3):475-86. PubMed ID: 24089118
[No Abstract] [Full Text] [Related]
7. Management of antiplatelet and anticoagulant therapy in patients with atrial fibrillation in the setting of acute coronary syndromes or percutaneous coronary interventions.
Capodanno D; Angiolillo DJ
Circ Cardiovasc Interv; 2014 Feb; 7(1):113-24. PubMed ID: 24550531
[No Abstract] [Full Text] [Related]
8. Diabetes and acute coronary syndromes.
Roffi M; Eberli FR
Best Pract Res Clin Endocrinol Metab; 2009 Jun; 23(3):305-16. PubMed ID: 19520305
[TBL] [Abstract][Full Text] [Related]
9. Triple antithrombotic therapy: risky but sometimes necessary.
Sørensen R; Gislason G
Rev Esp Cardiol (Engl Ed); 2014 Mar; 67(3):171-5. PubMed ID: 24774390
[No Abstract] [Full Text] [Related]
10. New anticoagulant agents in acute coronary syndromes.
Höchtl T; Farhan S; Wojta J; Huber K
Heart; 2011 Feb; 97(3):244-52. PubMed ID: 21189310
[No Abstract] [Full Text] [Related]
11. [Your patient needs antithrombotics, 2. What do the new substances offer? (interview by Dr. med. Peter Stiefelhagen)].
Stiefelhagen P
MMW Fortschr Med; 2013 Feb; 155(3):18. PubMed ID: 23573760
[No Abstract] [Full Text] [Related]
12. Current update on glycoprotein IIb-IIIa and direct thrombin inhibition in percutaneous coronary intervention for non-ST elevation acute coronary syndromes: balancing bleeding risk and antiplatelet efficacy.
Kwa AT; Rogers JH
J Interv Cardiol; 2008 Apr; 21(2):107-17. PubMed ID: 18248357
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic therapy for non ST-segment elevation acute coronary syndromes: focus on antithrombotic therapy.
Danchin N; Aïssaoui N
Cardiovasc Drugs Ther; 2010 Aug; 24(4):325-30. PubMed ID: 20714797
[TBL] [Abstract][Full Text] [Related]
14. Antiplatelet and anticoagulant agents: key differences in mechanisms of action, clinical application, and therapeutic benefit in patients with non-ST-segment-elevation acute coronary syndromes.
Jennings LK; Saucedo JF
Curr Opin Cardiol; 2008 Jul; 23(4):302-8. PubMed ID: 18520712
[TBL] [Abstract][Full Text] [Related]
15. Beyond unfractionated heparin and warfarin: current and future advances.
Hirsh J; O'Donnell M; Eikelboom JW
Circulation; 2007 Jul; 116(5):552-60. PubMed ID: 17664384
[No Abstract] [Full Text] [Related]
16. Treatment strategies in non-ST-elevation acute coronary syndromes in patients undergoing percutaneous coronary intervention: an evidence-based review of clinical trial results and treatment guidelines: report on a roundtable discussion.
Cohen M; Hoekstra J; Giugliano R; Granger CB; Gurbel PA; Hollander JE; Manoukian SV; Pollack CV; Saucedo JF
J Interv Cardiol; 2008 Aug; 21(4):283-99. PubMed ID: 18754964
[TBL] [Abstract][Full Text] [Related]
17. Clopidogrel, prasugrel, or ticagrelor? a practical guide to use of antiplatelet agents in patients with acute coronary syndromes.
Norgard NB; Dinicolantonio JJ
Postgrad Med; 2013 Jul; 125(4):91-102. PubMed ID: 23933898
[TBL] [Abstract][Full Text] [Related]
18. Antiplatelet therapy in acute coronary syndromes.
Barker CM; Price MJ
Curr Cardiol Rep; 2008 Jul; 10(4):327-33. PubMed ID: 18611368
[TBL] [Abstract][Full Text] [Related]
19. [Contribution of the new oral anticoagulants to the treatment of acute coronary syndrome].
Fernández D; Penela D; Heras M
Med Clin (Barc); 2012 Oct; 139 Suppl 2():41-5. PubMed ID: 23498072
[TBL] [Abstract][Full Text] [Related]
20. A new era of antithrombotic therapy in patients with atrial fibrillation.
Golwala H; Dib C; Tafur A; Abu-Fadel MS
Am J Med Sci; 2012 Aug; 344(2):128-35. PubMed ID: 22245946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
